year
111Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 42971-09-5 | ||
EC NO: | 256-028-0 | ||
Molecular Formula: | C22H27N2O2 | ||
Molecular Weight: | 351.4614 | ||
Specification: | 99% | ||
InChI: | InChI=1/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3/p+1/t20-,22+/m1/s1 | ||
Packing: | 25kg/drum | ||
Product description: Action : 1. It has vasodilating, blood thinning, and memory-enhancing actions. 2. It acts as a cerebral stimulant and vasodilator. 3. It is used to treat arteriosclerosis. 4. It is very effective in curing dementia caused due to insufficient blood supply to the brain. 5. It interferes with cells' ability to synthesize DNA and RNA. |
|||
Uses: | used in medicine | ||
Synonyms: | (+)-Apovincaminic acid ethyl ester;(+)-cis-Apovincaminic acid ethyl ester;3-alpha,16-alpha-Apovincaminic acid ethyl ester;AY 27,255;Apovincaminate d'ethyle;Apovincaminate d'ethyle [French];Apovincaminic acid ethyl ester;BRN 0900803;Cavinton;Ethyl (+)-apovincaminate;Ethyl (+)-cis-apovincaminate;Ethyl apovincamin-22-oate;RGH 4405;RGH-4405;TCV-3B;UNII-543512OBTC;Vinpocetinum;Vinpocetinum [INN-Latin];cis-Apovincaminic acid ethyl ester;Eburnamenine-14-carboxylic acid, ethyl ester, (3-alpha,16-alpha)-;Eburnamenine-14-carboxylic acid, ethyl ester, (3alpha,16alpha)-;ethyl eburnamenine-14-carboxylate;ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate;(3alpha,16alpha)-14-(ethoxycarbonyl)eburnamenin-4-ium; | ||
Molecular Structure: |